MHMaria Handke

Maria Handke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Handke has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Phenazine Biosynthesis Inhibitors as Pseudomonas aeruginosa Antivirulence Agents

    by Maria Handke, Janosch Baumgarten, Marie Thiemann, Moritz Zimmermann, Martin Empting, Lars E. P. Dietrich, Conrad Kunick, Wulf Blankenfeldt, Matthias Schiedel

    Phenazines are redox-active secondary metabolites produced by a variety of bacteria, including Pseudomonas aeruginosa, a Gram-negative opportunistic pathogen associated with severe, often chronic infections and particularly notorious for its multiple resistance mechanisms. A major contributor to P. aeruginosa virulence and resistance is the production of phenazine-derived metabolites such as pyocyanin, which play central roles in biofilm formation, redox homeostasis, and host tissue damage. Consequently, inhibition of phenazine biosynthesis may be an attractive pathoblocker strategy aimed at attenuating bacterial virulence without exerting bactericidal pressure, thus reducing the development of drug resistance. Over the past years, considerable progress has been made in the identification and characterization of small-molecule inhibitors targeting this pathway. These advances have been driven by interdisciplinary efforts, with medicinal chemistry, chemical biology, and structural biology providing key insights into target tractability, ligand binding modes, and structure–activity relationships. In this review, we summarize recent developments in phenazine biosynthesis inhibition, highlighting representative inhibitors and discussing biological and structural data for enzymes across the pathway.

  • Open Access

    From Bones to Bugs: Structure-Based Development of Raloxifene-Derived Pathoblockers That Inhibit Pyocyanin Production in Pseudomonas aeruginosa

    by Marie Thiemann, Moritz Zimmermann, Christina Diederich, Huilin Zhan, Mikhail Lebedev, Jakob Pletz, Janosch Baumgarten, Maria Handke, Mathias Müsken, Rolf Breinbauer, et al.

    The human pathogen Pseudomonas aeruginosa is particularly notorious for its multiple resistance mechanisms. A new concept for anti-infectives is the "pathoblocker" approach, which targets virulence factors to disarm rather than kill pathogens and thus attenuates the development of resistance. Based on the estrogen receptor modulator raloxifene, which had previously been identified as a potential biosynthesis inhibitor of the virulence factor pyocyanin via in silico screening, analogues have been developed as pathoblockers against P. aeruginosa. These compounds reduce the production of pyocyanin by binding to the phenazine biosynthesis enzyme PhzB. Structure-activity relationships (SAR) were explored using nano differential scanning fluorimetry, isothermal titration calorimetry, and 12 X-ray cocrystal structures. Compared to raloxifene, congener 20c shows a 60-fold lower affinity for the human estrogen receptor with a 15-fold increase in pyocyanin inhibitory activity. The comprehensive structural information gathered in this study paves the way for the development of improved pathoblockers with increased potency and selectivity.


  • Open Access

    New fluorogenic triacylglycerols as sensors for dynamic measurement of lipid oxidation

    by Maria Handke, Frank Beierlein, Petra Imhof, Matthias Schiedel, Simon Hammann

    Lipids are major constituents of food but are also highly relevant substructures of drugs and are increasingly applied for the development of lipid-based drug delivery systems. Lipids are prone to oxidative degradation, thus affecting the quality of food or medicines. Therefore, analytical methods or tools that enable to assess the degree of lipid oxidation are of utmost importance to guarantee food and drug safety. Herein, we report the design, synthesis, and application of the first-in-class fluorogenic triacylglycerols that enable a dynamic monitoring of lipid oxidation via straightforward fluorescence readout. Our fluorogenic triacylglycerols can be used both in an aqueous and lipid-based environment. Further, we showed that the sensitivity of our fluorescent tracers towards oxidation can be tuned by incorporating either saturated or unsaturated acyl chains in their triacylglycerol core structure. With this, we provide a first proof-of-principle for the applicability of fluorescently labelled triacylglycerols as tracers to monitor the dynamics of lipid oxidation, thus paving the way for novel discoveries in the area of lipid analytics.